Correlation Between Immix Biopharma and Cerevel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Immix Biopharma and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Cerevel Therapeutics.
Diversification Opportunities for Immix Biopharma and Cerevel Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Immix and Cerevel is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Cerevel Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and Cerevel Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to generate 1.2 times more return on investment than Cerevel Therapeutics. However, Immix Biopharma is 1.2 times more volatile than Cerevel Therapeutics Holdings. It trades about 0.04 of its potential returns per unit of risk. Cerevel Therapeutics Holdings is currently generating about -0.01 per unit of risk. If you would invest 150.00 in Immix Biopharma on September 1, 2024 and sell it today you would earn a total of 61.00 from holding Immix Biopharma or generate 40.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 83.23% |
Values | Daily Returns |
Immix Biopharma vs. Cerevel Therapeutics Holdings
Performance |
Timeline |
Immix Biopharma |
Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immix Biopharma and Cerevel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immix Biopharma and Cerevel Therapeutics
The main advantage of trading using opposite Immix Biopharma and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |